NALYNE DOM: Open Payments
NPI 1427424845 · LOWELL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 29 payments from 12 companies in 2025. Trend: 2023 $206 · 2024 $836 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $412 |
| Novo Nordisk Inc | 2 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Amgen Inc. | 2 | $58 |
| Lilly USA, LLC | 2 | $50 |
| Lundbeck LLC | 2 | $49 |
| PFIZER INC. | 2 | $46 |
| Exact Sciences Corporation | 1 | $27 |
| Ardelyx, Inc. | 1 | $23 |
Products named: BREZTRI, AIRSUPRA, Ozempic, REXULTI, FARXIGA, Kerendia, PREVNAR 20, EVENITY.
Industry payments across MA — which companies pay providers there.
